# Processa Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Feb 23, 2026

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-23
- Accepted by EDGAR: Feb 23, 2026, 11:00 ET
- Period: not reported
- Accession: 0002081456-26-000002
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000208145626000002/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000208145626000002/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000208145626000002/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 23, 2026.
Source: SEC EDGAR, the filing index for accession 0002081456-26-000002. Last ingested by Listed: Nov 5, 2026, 12:19 ET. No prices; not investment advice.